Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 27, Issue 6, pp. 1792-1806
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 29, 2020
- Revision received November 4, 2020
- Accepted December 14, 2020
- Published first December 17, 2020.
Article Versions
- Previous version (December 17, 2020 - 06:02).
- Previous version (January 21, 2021 - 09:40).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Goutam Chakraborty1,#,*,
- Nabeela Khan Patail1,#,
- Rahim Hirani1,
- Subhiksha Nandakumar2,
- Ying Z. Mazzu1,
- Yuki Yoshikawa1,
- Mohammad Atiq1,
- Lina E. Jehane1,
- Konrad H. Stopsack1,
- Gwo-Shu Mary Lee3,
- Wassim Abida1,
- Michael J. Morris1,
- Lorelei A. Mucci4,
- Daniel Danila1, and
- Philip W. Kantoff1,*
- 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
- 2Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
- 3Dana-Farber Cancer Institute, Boston, Massachusetts.
- 4Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- ↵*Corresponding Authors:
Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. Phone: 212-639-5851; Fax: 929-321-5023; E-mail: kantoff{at}mskcc.org; and Goutam Chakraborty, E-mail: chakrabg{at}mskcc.org
↵#G. Chakraborty and N. Khan Patail contributed equally as co-first authors of this article.
March 2021
Volume 27, Issue 6
Volume 27, Issue 6
Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors
Jump to section
Advertisement